2024年3月1日 · Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who are on dialysis. Includes Renvela side effects, interactions and indications.

2023年6月20日 · Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. The recommended starting dose of Renvela is 0.8 to 1.6 g taken orally with meals based on serum phosphorus level.

Renvela ® (sevelamer carbonate) is used to control phosphorus levels in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Do not use Renvela if you have a history of bowel obstruction or if you are allergic to sevelamer carbonate, sevelamer hydrochloride, or to any of the ingredients in Renvela.

2024年11月27日 · Sevelamer helps prevent hypocalcemia (low levels of calcium in the body) caused by elevated phosphorus. Sevelamer is used to control phosphorus levels in people with chronic kidney disease who are on dialysis. Sevelamer may also be used for purposes not listed in this medication guide.

Renvela (sevelamer carbonate) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. Because of the rapid reaction with the hydrochloric...

2023年9月27日 · Renvela ® (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. 2. Renvela Dosage and Administration. Starting Dose for Adult Patients Not Taking a Phosphate Binder.

Sevelamer is available as Renagel, Renvela, and generic sevelamer in the following dosage forms that are taken by mouth. 400 mg oral tablets ; 800 mg oral tablets ; 0.8 g powder for...

2016年8月6日 · Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. Because of the rapid reaction with the hydrochloric acid in the stomach, the dosing of Renvela powder or tablet is anticipated to be similar to that of the sevelamer hydrochloride salt or ...

It is used specifically to control high levels of phosphate (and therefore phosphorus) in the blood of people with severe kidney disease, known as end stage renal disease (ESRD), who are receiving dialysis (hemodialysis or peritoneal dialysis). This medication may be available under multiple brand names and/or in several different forms.

Renvela is a type of medicine known as a phosphate binder. It should be taken three times a day with meals to help control phosphorus levels in your body. Renvela binds to (or holds on to) phosphorus in the foods you eat so your body doesn’t absorb as much. Then it carries the phosphorus through your digestive tract and out of your body.